Tracked deals
3
3 tracked deals across 2019-2026.
Parsippany, New Jersey, United States
Zoetis is the world’s leading animal health company, pioneering ways to predict, prevent, detect, and treat animal illness—supporting veterinarians, livestock producers, and pet owners in over 100 countries.
Tracked deals
3
3 tracked deals across 2019-2026.
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout
Last 2 years
Supporting Data
Zoetis has agreed to acquire VitalRADS, a veterinary teleradiology services platform, to expand its diagnostic imaging, specialist services, and workflow technology capabilities. The acquisition is intended to strengthen Zoetis’ Global Diagnostics portfolio by enabling around-the-clock access to board-certified specialists and AI-assisted report generation as part of a more comprehensive virtual reference lab. The deal is expected to close in the third quarter of 2026, subject to customary conditions and regulatory approvals.
Zoetis announced it has entered into a definitive agreement to acquire Neogen Corporation’s animal genomics business for $160 million, subject to customary closing adjustments. The deal is intended to strengthen Zoetis’ leadership in Precision Animal Health by integrating Neogen’s genomic technologies and data solutions to expand predictive insights and individualized care.
Zoetis Inc. has completed the acquisition of Platinum Performance, a privately held, nutrition-focused animal health company based in Buellton, California. Platinum Performance will operate as a wholly owned subsidiary of Zoetis and continue to be led by Mark Herthel from its Buellton headquarters; financial terms were not disclosed.
Turn tracked acquisition activity into an outreach-ready buyer list.